Milestone scientific reports revenue of $2.2 million and provides business update for the first quarter of 2024

Sales through new online portal increase 31% over the same period last year gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year reports steady progress on reimbursement strategy for the compuflo® epidural system roseland, n.j., may 16, 2024 (globe newswire) -- milestone scientific inc. (nyse: mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and announces financial results for the first quarter ended march 31, 2024.
MLSS Ratings Summary
MLSS Quant Ranking